Low hepatitis C prevalence in Belgium: implications for treatment reimbursement and scale up

Low hepatitis C prevalence in Belgium: implications for treatment reimbursement and scale up

Abstract Background Prevalence data of chronic hepatitis C virus (HCV) infection are needed to estimate the budgetary impact of reimbursement of direct-acting antivirals (DAAs). In Belgium, the restricted reimbursement criteria are mainly guided by regional seroprevalence estimates of 0.87% from 199...

Full description

Saved in:
Bibliographic Details
Main Authors: Amber Litzroth (Author), Vanessa Suin (Author), Chloé Wyndham-Thomas (Author), Sophie Quoilin (Author), Gaëtan Muyldermans (Author), Thomas Vanwolleghem (Author), Benoît Kabamba-Mukadi (Author), Vera Verburgh (Author), Marjorie Jacques (Author), Steven Van Gucht (Author), Veronik Hutse (Author)
Format: Book
Published: BMC, 2019-01-01T00:00:00Z.
Subjects:
article
Online Access:Connect to this object online.
Tags: Add Tag
No Tags, Be the first to tag this record!

Internet

Connect to this object online.

3rd Floor Main Library

Holdings details from 3rd Floor Main Library
Call Number: A1234.567
Copy 1 Available

Similar Items